The Transcatheter Heart Valve (THV) market is a segment of the Cardiovascular Devices industry. THV devices are used to replace or repair a patient's heart valve without the need for open-heart surgery. This minimally invasive procedure is often used to treat aortic stenosis, a narrowing of the aortic valve. THV devices are typically made of biocompatible materials such as polyester, nitinol, and polyurethane. They are designed to be inserted through a catheter and deployed in the heart. The THV market is expected to grow due to the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive procedures. The market is also driven by the increasing number of clinical trials and the availability of reimbursement policies. Some of the major companies in the THV market include Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, and LivaNova. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
